HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED
Last Updated: 13 Apr 2026
At Hummingbird Bioscience, we are dedicated to leveraging cutting-edge computational and systems biology approaches to identify and develop innovative biotherapeutics for challenging diseases. Our collaborative, multi-disciplinary approach integrates state-of-the-art techniques throughout the drug discovery and development process, allowing us to streamline the translation of scientific breakthroughs into clinical reality. With a steadfast commitment to rigor, teamwork, and intellectual integrity, we are passionate about accelerating the journey of new drugs from concept to clinic.
Country of registration | Singapore |
Registration number | 201540910W |
Local SIC | |
Incorporation date | 18 Nov 2015 |
Company age | 10 years 6 months |
Official entity type | Public Company Limited By Shares |
No. of officers | 98 |
Contact
Address:
61 SCIENCE PARK ROAD, #06-15, THE GALEN, Singapore 117525
Access Key Decision Makers
This is the legal entity page of HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- HUMMINGBIRD BIOSCIENCEView MoreSingaporeAt Hummingbird Bioscience, we are dedicated to leveraging cutting-edge computational and systems biology approaches to identify and develop innovative biotherapeutics for challenging diseases. Our collaborative, multi-disciplinary approach integrates state-of-the-art techniques throughout the drug discovery and development process, allowing us to streamline the translation of scientific breakthroughs into clinical reality. With a steadfast commitment to rigor, teamwork, and intellectual integrity, we are passionate about accelerating the journey of new drugs from concept to clinic.
This is the legal entity page of HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | October - December |
Auditor | ERNST & YOUNG LLP |
Revenue | 11m - 25m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | USD 318,277 |
Share Capital - Preference shares | USD 159,911,360 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED?
- Where is HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED's headquarter?
- What is HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED's contact number?
- What HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED's spending power?
- Does HUMMINGBIRD BIOSCIENCE HOLDINGS LIMITED have a presence in the domain it operates in?